Evelim Leal de Freitas Dantas Gomes
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Evelim Leal de Freitas Dantas Gomes has a total of 157 co-authors. Here are the top co-authors by number of shared publications:
- Dirceu Costa
Nove de Julho University, São Paulo, Brazil
20 shared publications - Luciana Maria Malosá Sampaio
Universidade Nove de Julho, São Paulo, Brazil
8 shared publications Dirceu Costa
Nove de Julho University, São Paulo, Brazil
7 shared publications- Etiene Farah Teixeira de Carvalho
Universidade Nove de Julho, São Paulo SP, Brazil
5 shared publications Roberto Stirbulov
Santa Casa de Misericórdia São Paulo Hospital, Brazil
4 shared publications- Cristiane Aparecida Moran
Universidade Federal de Santa Catarina
3 shared publications
Latest Publications
- Open Access
- 18 November 2026
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 34 (12)
Association between COPD and functional disability in adults with a history of cancer: a cross-sectional analysis of ELSI-Brazil
Purpose: To explore associations between chronic obstructive pulmonary disease (COPD) and functional disability across mobility, instrumental activities of daily living (IADL), and basic activities of daily living (BADL) among Brazilian adults with a history of cancer. Methods: This cross-sectional study used data from ELSI-Brazil. Participants aged 50 years and older with a self-reported history of cancer were classified according to self-reported physician-diagnosed COPD status. Functional disability was assessed across three domains: mobility, IADL, and BADL. Logistic regression was used to estimate odds ratios (ORs). Bonferroni and Benjamini–Hochberg corrections were applied only to the unadjusted outcome-specific tests. Sensitivity analyses included Firth’s penalized logistic regression. Results: Among 504 participants with a history of cancer, 502 had available information on COPD status, of whom 42 (8.4%) reported COPD. In unadjusted analyses, COPD was nominally associated with higher odds of difficulty running 1 km (OR = 4.57; 95%CI: 1.08–19.28) and walking 1 km (OR = 2.31; 95%CI: 1.21–4.42). After adjustment for age, sex, smoking status, and the number of other comorbidities, the corresponding ORs were 4.77 (95%CI: 1.12–20.39) and 2.47 (95%CI: 1.25–4.88), respectively. Neither unadjusted association remained statistically significant after multiplicity correction. The multivariable and Firth analyses were not corrected for multiple testing. No nominally significant associations were observed for IADL or BADL. Conclusion: In this exploratory study, self-reported COPD showed nominal associations with greater difficulty performing selected mobility activities among adults with a history of cancer. These findings were not robust to correction for multiple comparisons and should be interpreted cautiously.
- 18 November 2026
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 34 (12)
Open AccessAssociation between COPD and functional disability in adults with a history of cancer: a cross-sectional analysis of ELSI-Brazil
Purpose: To explore associations between chronic obstructive pulmonary disease (COPD) and functional disability across mobility, instrumental activities of daily living (IADL), and basic activities of daily living (BADL) among Brazilian adults with a history of cancer. Methods: This cross-sectional study used data from ELSI-Brazil. Participants aged 50 years and older with a self-reported history of cancer were classified according to self-reported physician-diagnosed COPD status. Functional disability was assessed across three domains: mobility, IADL, and BADL. Logistic regression was used to estimate odds ratios (ORs). Bonferroni and Benjamini–Hochberg corrections were applied only to the unadjusted outcome-specific tests. Sensitivity analyses included Firth’s penalized logistic regression. Results: Among 504 participants with a history of cancer, 502 had available information on COPD status, of whom 42 (8.4%) reported COPD. In unadjusted analyses, COPD was nominally associated with higher odds of difficulty running 1 km (OR = 4.57; 95%CI: 1.08–19.28) and walking 1 km (OR = 2.31; 95%CI: 1.21–4.42). After adjustment for age, sex, smoking status, and the number of other comorbidities, the corresponding ORs were 4.77 (95%CI: 1.12–20.39) and 2.47 (95%CI: 1.25–4.88), respectively. Neither unadjusted association remained statistically significant after multiplicity correction. The multivariable and Firth analyses were not corrected for multiple testing. No nominally significant associations were observed for IADL or BADL. Conclusion: In this exploratory study, self-reported COPD showed nominal associations with greater difficulty performing selected mobility activities among adults with a history of cancer. These findings were not robust to correction for multiple comparisons and should be interpreted cautiously.
- Open Access
- 1 October 2026
- Published by Wiley in Pediatric Pulmonology
- Vol. 61 (10)
Test‐Retest Reliability, Learning Effect and Measurement Error of the Modified Shuttle Test (MST) in Children With Asthma: A Multicenter Study
Objective: To investigate test‐retest reliability, measurement error (standard error of measurement [SEM] and minimum detectable difference [MDD]), and the learning effect of the Modified Shuttle Test (MST) in children with asthma. Methods: Multicenter cross‐sectional study including clinically stable children aged 6–12 years with asthma. Lung function and exercise capacity were assessed using MST. Intraclass Correlation Coefficient (ICC) was calculated to assess test‐retest reliability. The first and second tests were compared using the paired Student's t‐ test to assess differences between tests. SEM and MDD were calculated to quantify measurement error. Results: One hundred and twenty three children were included (71 boys [57%]; median age 9 [7–10] years). The mean distance covered in the best MST was 611 ± 214 meters (confidence interval [95% CI] = 573–649meters). The MST showed an excellent test‐retest reliability (ICC = 0.96; 95% CI: 0.95–0.97). Distance was significantly lower in the second test than in the first (574 ± 218 vs. 601 ± 216 m; p = 0.0001). Learning effect was −27 ± 79 (4% ± 14%), the SEM was 56 meters (9.5%), and the MDD was 156 m (26.6%). Conclusion: The MST demonstrated excellent test–retest reliability and acceptable measurement error for assessing exercise capacity in children with asthma. Although a systematic difference was observed between tests, there was no evidence of a consistent learning effect, with individual variability in repeated performance.
- 1 October 2026
- Published by Wiley in Pediatric Pulmonology
- Vol. 61 (10)
Open AccessTest‐Retest Reliability, Learning Effect and Measurement Error of the Modified Shuttle Test (MST) in Children With Asthma: A Multicenter Study
Objective: To investigate test‐retest reliability, measurement error (standard error of measurement [SEM] and minimum detectable difference [MDD]), and the learning effect of the Modified Shuttle Test (MST) in children with asthma. Methods: Multicenter cross‐sectional study including clinically stable children aged 6–12 years with asthma. Lung function and exercise capacity were assessed using MST. Intraclass Correlation Coefficient (ICC) was calculated to assess test‐retest reliability. The first and second tests were compared using the paired Student's t‐ test to assess differences between tests. SEM and MDD were calculated to quantify measurement error. Results: One hundred and twenty three children were included (71 boys [57%]; median age 9 [7–10] years). The mean distance covered in the best MST was 611 ± 214 meters (confidence interval [95% CI] = 573–649meters). The MST showed an excellent test‐retest reliability (ICC = 0.96; 95% CI: 0.95–0.97). Distance was significantly lower in the second test than in the first (574 ± 218 vs. 601 ± 216 m; p = 0.0001). Learning effect was −27 ± 79 (4% ± 14%), the SEM was 56 meters (9.5%), and the MDD was 156 m (26.6%). Conclusion: The MST demonstrated excellent test–retest reliability and acceptable measurement error for assessing exercise capacity in children with asthma. Although a systematic difference was observed between tests, there was no evidence of a consistent learning effect, with individual variability in repeated performance.
- 5 September 2026
- Published by European Respiratory Society (ERS)
- Vol. 68 (suppl 70) , PA1772
Quality of Life and Airway Inflammation in Children with Asthma: Integrating Clinical, Functional, and ICF-Based Measures
Background: Asthma is a prevalent chronic disease in childhood, with substantial impact on daily activities and participation. Although airway inflammation is central to asthma pathophysiology, its association with functional status and quality of life is still insufficiently explored within a biopsychosocial framework. Methods: This cross-sectional study included 112 children and adolescents with clinically diagnosed asthma attending a pediatric respiratory physiotherapy clinic. Fractional exhaled nitric oxide (FeNO) was used as a marker of eosinophilic airway inflammation, and quality of life was assessed using the Pediatric Asthma Quality of Life Questionnaire. Clinical and subjective variables were linked to categories of the International Classification of Functioning, Disability and Health, covering body functions and activities/participation, and converted into functional impairment levels. Participants were stratified by FeNO (<35 vs ≥35 ppb). Group comparisons were performed using Welch’s t-test, with effect sizes calculated using Cohen’s d. Results: Mean age was 8.9 ± 2.7 years and mean FeNO was 47.1 ± 38.6 ppb. Children with FeNO ≥35 ppb showed significantly worse quality-of-life scores across symptom, emotional, and activity domains, as well as higher global functional impairment based on ICF coding (all p < 0.05). Effect sizes were large (Cohen’s d ≥0.8). Conclusion: Higher airway inflammation is associated with poorer quality of life and greater functional limitation in children with asthma. Integrating inflammatory biomarkers with ICF-based functional assessment offers a comprehensive perspective relevant to respiratory physiotherapy and supports interventions addressing both clinical control and participation.
- 5 September 2026
- Published by European Respiratory Society (ERS)
- Vol. 68 (suppl 70) , PA1772
Quality of Life and Airway Inflammation in Children with Asthma: Integrating Clinical, Functional, and ICF-Based Measures
Background: Asthma is a prevalent chronic disease in childhood, with substantial impact on daily activities and participation. Although airway inflammation is central to asthma pathophysiology, its association with functional status and quality of life is still insufficiently explored within a biopsychosocial framework. Methods: This cross-sectional study included 112 children and adolescents with clinically diagnosed asthma attending a pediatric respiratory physiotherapy clinic. Fractional exhaled nitric oxide (FeNO) was used as a marker of eosinophilic airway inflammation, and quality of life was assessed using the Pediatric Asthma Quality of Life Questionnaire. Clinical and subjective variables were linked to categories of the International Classification of Functioning, Disability and Health, covering body functions and activities/participation, and converted into functional impairment levels. Participants were stratified by FeNO (<35 vs ≥35 ppb). Group comparisons were performed using Welch’s t-test, with effect sizes calculated using Cohen’s d. Results: Mean age was 8.9 ± 2.7 years and mean FeNO was 47.1 ± 38.6 ppb. Children with FeNO ≥35 ppb showed significantly worse quality-of-life scores across symptom, emotional, and activity domains, as well as higher global functional impairment based on ICF coding (all p < 0.05). Effect sizes were large (Cohen’s d ≥0.8). Conclusion: Higher airway inflammation is associated with poorer quality of life and greater functional limitation in children with asthma. Integrating inflammatory biomarkers with ICF-based functional assessment offers a comprehensive perspective relevant to respiratory physiotherapy and supports interventions addressing both clinical control and participation.
- 8 April 2026
- Published by Elsevier in Respiratory Medicine
- Vol. 256, 108819
Functional and structural respiratory impairment in cerebral palsy- GMFCS IV and V: Insights from ultrasound and inspiratory muscle testing
- 8 April 2026
- Published by Elsevier in Respiratory Medicine
- Vol. 256, 108819
Functional and structural respiratory impairment in cerebral palsy- GMFCS IV and V: Insights from ultrasound and inspiratory muscle testing
- 20 March 2026
- Published by Wiley in Physiotherapy Research International
- Vol. 31 (2) , e70184
Quality of Life and Airway Inflammation in Children With Asthma: Integrating Clinical and Functional Measures Through the International Classification of Functioning (ICF)
Background and Purpose: Asthma is one of the most prevalent chronic diseases in childhood and a major cause of respiratory morbidity, school absenteeism, and restrictions in physical activity. Although asthma control is commonly assessed using clinical and inflammatory markers, its functional impact on daily activities and participation is less frequently addressed. Fractional exhaled nitric oxide (FeNO) is a well‐established biomarker of eosinophilic airway inflammation; however, its integration with quality‐of‐life measures within a biopsychosocial framework, such as the International Classification of Functioning, Disability and Health (ICF), remains limited. This study aimed to examine the associations between quality of life, airway inflammation, and functional status in children and adolescents with asthma using the ICF as a conceptual integrative framework. Methods: This cross‐sectional study included 112 children and adolescents with clinically diagnosed asthma receiving care at a pediatric respiratory physiotherapy clinic. Data collection comprised demographic and anthropometric variables, FeNO levels, and Pediatric Asthma Quality of Life Questionnaire (PAQLQ) scores. Clinical and patient‐reported outcomes were conceptually linked to ICF categories related to body functions and activities and participation and expressed as functional impairment levels (0–4) for descriptive and comparative purposes. Descriptive analyses were performed, and participants were stratified according to FeNO levels (< 35 vs. ≥ 35 ppb). Group comparisons were conducted using Welch's t ‐test, with effect sizes estimated using Cohen's d ( p < 0.05). Results: The sample had a mean age of 8.9 ± 2.7 years and a mean FeNO level of 47.1 ± 38.6 ppb. Overall PAQLQ scores indicated relatively preserved perceived quality of life across domains. ICF‐based descriptive analysis indicated predominantly mild‐to‐moderate limitations in activity‐ and symptom‐related domains and minimal emotional impairment, with a mean global ICF score of 1.5 ± 0.6. Participants with FeNO ≥ 35 ppb presented lower PAQLQ scores in symptoms, emotions, and activities, as well as higher global ICF scores, compared with those with FeNO < 35 ppb (all p ≤ 0.05). Effect sizes were large (Cohen's d ≥ 0.8). Discussion: Higher FeNO levels were associated with poorer quality‐of‐life scores and greater functional impairment. The conceptual integration of FeNO and PAQLQ findings within the ICF framework facilitated the interpretation of inflammatory status in relation to functional domains relevant to physiotherapy without implying causality. This approach supports a more comprehensive understanding of asthma‐related functioning in children and adolescents.
- 20 March 2026
- Published by Wiley in Physiotherapy Research International
- Vol. 31 (2) , e70184
Quality of Life and Airway Inflammation in Children With Asthma: Integrating Clinical and Functional Measures Through the International Classification of Functioning (ICF)
Background and Purpose: Asthma is one of the most prevalent chronic diseases in childhood and a major cause of respiratory morbidity, school absenteeism, and restrictions in physical activity. Although asthma control is commonly assessed using clinical and inflammatory markers, its functional impact on daily activities and participation is less frequently addressed. Fractional exhaled nitric oxide (FeNO) is a well‐established biomarker of eosinophilic airway inflammation; however, its integration with quality‐of‐life measures within a biopsychosocial framework, such as the International Classification of Functioning, Disability and Health (ICF), remains limited. This study aimed to examine the associations between quality of life, airway inflammation, and functional status in children and adolescents with asthma using the ICF as a conceptual integrative framework. Methods: This cross‐sectional study included 112 children and adolescents with clinically diagnosed asthma receiving care at a pediatric respiratory physiotherapy clinic. Data collection comprised demographic and anthropometric variables, FeNO levels, and Pediatric Asthma Quality of Life Questionnaire (PAQLQ) scores. Clinical and patient‐reported outcomes were conceptually linked to ICF categories related to body functions and activities and participation and expressed as functional impairment levels (0–4) for descriptive and comparative purposes. Descriptive analyses were performed, and participants were stratified according to FeNO levels (< 35 vs. ≥ 35 ppb). Group comparisons were conducted using Welch's t ‐test, with effect sizes estimated using Cohen's d ( p < 0.05). Results: The sample had a mean age of 8.9 ± 2.7 years and a mean FeNO level of 47.1 ± 38.6 ppb. Overall PAQLQ scores indicated relatively preserved perceived quality of life across domains. ICF‐based descriptive analysis indicated predominantly mild‐to‐moderate limitations in activity‐ and symptom‐related domains and minimal emotional impairment, with a mean global ICF score of 1.5 ± 0.6. Participants with FeNO ≥ 35 ppb presented lower PAQLQ scores in symptoms, emotions, and activities, as well as higher global ICF scores, compared with those with FeNO < 35 ppb (all p ≤ 0.05). Effect sizes were large (Cohen's d ≥ 0.8). Discussion: Higher FeNO levels were associated with poorer quality‐of‐life scores and greater functional impairment. The conceptual integration of FeNO and PAQLQ findings within the ICF framework facilitated the interpretation of inflammatory status in relation to functional domains relevant to physiotherapy without implying causality. This approach supports a more comprehensive understanding of asthma‐related functioning in children and adolescents.
- Open Access
- 14 August 2025
- Published by Elsevier in Global Pediatrics
- Vol. 14
Analysis of the motor proficiency and physical capacity of asthmatic children and adolescents: A cross-sectional study
- 14 August 2025
- Published by Elsevier in Global Pediatrics
- Vol. 14
Open AccessAnalysis of the motor proficiency and physical capacity of asthmatic children and adolescents: A cross-sectional study
- 18 June 2025
- Published by SAGE Publications in Clinical Pediatrics
- Vol. 64 (11) , 1549-1558
Associations Between Sleep Quality and Asthma Control, Pulmonary Inflammation, Asthma Severity, Exercise Capacity, and Quality of Life in Children With Asthma: A Cross-sectional Study
Asthma is a condition characterized by ongoing inflammation of the lower respiratory system, leading to symptoms such as shortness of breath, wheezing, coughing, and chest tightness. Beyond acute symptoms, children with asthma may face ongoing issues, such as decreased physical fitness, sleep disturbances, and a reduced quality of life. This study aimed to explore the connections between sleep quality, asthma control, pulmonary inflammation, exercise capacity, and overall wellbeing in children aged 6 to 12 years. Forty children with varying asthma severity were evaluated for clinical control status, sleep disturbances, quality of life, and exercise ability using various questionnaires and tests. Results showed that 15% had intermittent/mild asthma while 85% had moderate/severe asthma, with 75% experiencing uncontrolled asthma. The analysis indicated a strong correlation between improved asthma control, reduced pulmonary inflammation, better sleep quality, and enhanced quality of life, accounting for 20% of the variations in the children’s quality of life scores.
- 18 June 2025
- Published by SAGE Publications in Clinical Pediatrics
- Vol. 64 (11) , 1549-1558
Associations Between Sleep Quality and Asthma Control, Pulmonary Inflammation, Asthma Severity, Exercise Capacity, and Quality of Life in Children With Asthma: A Cross-sectional Study
Asthma is a condition characterized by ongoing inflammation of the lower respiratory system, leading to symptoms such as shortness of breath, wheezing, coughing, and chest tightness. Beyond acute symptoms, children with asthma may face ongoing issues, such as decreased physical fitness, sleep disturbances, and a reduced quality of life. This study aimed to explore the connections between sleep quality, asthma control, pulmonary inflammation, exercise capacity, and overall wellbeing in children aged 6 to 12 years. Forty children with varying asthma severity were evaluated for clinical control status, sleep disturbances, quality of life, and exercise ability using various questionnaires and tests. Results showed that 15% had intermittent/mild asthma while 85% had moderate/severe asthma, with 75% experiencing uncontrolled asthma. The analysis indicated a strong correlation between improved asthma control, reduced pulmonary inflammation, better sleep quality, and enhanced quality of life, accounting for 20% of the variations in the children’s quality of life scores.
- 16 April 2025
- Published by Elsevier in Early Human Development
- Vol. 205, 106267
Effect of muscle mass on neuropsychomotor development in newborns: A comparative analysis between preterm and full-term infants
- 16 April 2025
- Published by Elsevier in Early Human Development
- Vol. 205, 106267
Effect of muscle mass on neuropsychomotor development in newborns: A comparative analysis between preterm and full-term infants
- Open Access
- 8 October 2024
- Published by Universidade de São Paulo. Agência de Bibliotecas e Coleções Digitais in Medicina (Ribeirão Preto)
- Vol. 57 (1)
Uso de dexmedetomidina no manejo da ventilação mecânica não invasiva em pacientes pediátricos
RESUMENIntroducción: La ventilación no invasiva se utiliza en pacientes pediátricos en una unidad de cuidados intensivos porque es eficaz para el tratamiento de la insuficiencia respiratoria relacionada con enfermedades respiratorias. Sin embargo, existe una alta tasa de fracaso debido a la inquietud. Por lo tanto, la dexmedetomidina se usa como agente de sedación primario o en el período periextubación. Objetivo: Realizar una revisión sistemática de estudios observacionales en pacientes pediátricos (0 a 18 años) durante ventilación mecánica no invasiva con dexmedetomidina. Métodos: Levantamiento sistemático de artículos publicados en las bases de datos PubMed/MedLine, EBSCO, EMBASE, Scielo, SCOPUS, Cochrane library, Google academic y ScienceDirect y revistas disponibles en el Portal de Publicaciones Periódicas de la Coordinación para el Perfeccionamiento del Personal de Educación Superior (Capes). No se limitó ningún período ni año para analizar críticamente los principales elementos relacionados con la interacción entre el fármaco dexmedetomidina, la población pediátrica y el uso de ventilación mecánica no invasiva. Resultados: El uso de dexmedetomidina en pacientes pediátricos con ventilación no invasiva fue positivo después de la extubación porque no provocó depresión del sistema ventilatorio y además tuvo una eficacia significativa en pacientes que presentaron agitación durante la ventilación no invasiva. Sin embargo, su uso durante la ventilación no invasiva ha tenido efectos adversos hemodinámicos como bradicardia e hipertensión, además de signos de abstinencia, que se han informado después de la suspensión del fármaco. Conclusión: Los resultados de los estudios observacionales mostraron dexmedetomidina positivamente en pacientes pediátricos con ventilación no invasiva después de la extubación, aunque puede tener efectos adversos como bradicardia e hipertensión.
- 8 October 2024
- Published by Universidade de São Paulo. Agência de Bibliotecas e Coleções Digitais in Medicina (Ribeirão Preto)
- Vol. 57 (1)
Open AccessUso de dexmedetomidina no manejo da ventilação mecânica não invasiva em pacientes pediátricos
RESUMENIntroducción: La ventilación no invasiva se utiliza en pacientes pediátricos en una unidad de cuidados intensivos porque es eficaz para el tratamiento de la insuficiencia respiratoria relacionada con enfermedades respiratorias. Sin embargo, existe una alta tasa de fracaso debido a la inquietud. Por lo tanto, la dexmedetomidina se usa como agente de sedación primario o en el período periextubación. Objetivo: Realizar una revisión sistemática de estudios observacionales en pacientes pediátricos (0 a 18 años) durante ventilación mecánica no invasiva con dexmedetomidina. Métodos: Levantamiento sistemático de artículos publicados en las bases de datos PubMed/MedLine, EBSCO, EMBASE, Scielo, SCOPUS, Cochrane library, Google academic y ScienceDirect y revistas disponibles en el Portal de Publicaciones Periódicas de la Coordinación para el Perfeccionamiento del Personal de Educación Superior (Capes). No se limitó ningún período ni año para analizar críticamente los principales elementos relacionados con la interacción entre el fármaco dexmedetomidina, la población pediátrica y el uso de ventilación mecánica no invasiva. Resultados: El uso de dexmedetomidina en pacientes pediátricos con ventilación no invasiva fue positivo después de la extubación porque no provocó depresión del sistema ventilatorio y además tuvo una eficacia significativa en pacientes que presentaron agitación durante la ventilación no invasiva. Sin embargo, su uso durante la ventilación no invasiva ha tenido efectos adversos hemodinámicos como bradicardia e hipertensión, además de signos de abstinencia, que se han informado después de la suspensión del fármaco. Conclusión: Los resultados de los estudios observacionales mostraron dexmedetomidina positivamente en pacientes pediátricos con ventilación no invasiva después de la extubación, aunque puede tener efectos adversos como bradicardia e hipertensión.
- Open Access
- 27 September 2024
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 183 (12) , 5511
On ultrasonography for normative values of diaphragmatic and peripheral muscle function in the newborn
- 27 September 2024
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 183 (12) , 5511
Open AccessOn ultrasonography for normative values of diaphragmatic and peripheral muscle function in the newborn